Topics
Glioblastoma | Treatment | Targeted therapy | Sunitinib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Sunitinib
Janssen JBE, Brahm CG, Driessen CML, Nuver J, Labots M,
Kouwenhoven MCM, Sanchez Aliaga E, Enting RH, de Groot JC,
Walenkamp AME, van Linde ME, Verheul HMW.
The
STELLAR trial: a phase II/III randomized trial of high-dose,
intermittent sunitinib in patients
with recurrent glioblastoma.
Brain
Commun. 2024 Jul 30;6(4):fcae241. doi:
10.1093/braincomms/fcae241. PMID:
39114330. Interventional study. ˍ